VeriMombis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification listed in ECHA Annex VI and no SCCS or CIR safety assessment identifying reproductive hazard for this polymer. Peer‑reviewed or regulatory literature does not report teratogenicity or reproductive toxicity for the polymer itself; concerns would be about residual monomers such as HEMA or isocyanates, but no data show reproductive effects from the finished polymer as used in cosmetics (sources consulted: ECHA Annex VI, SCCS/CIR absence, PubMed absence).
Related ingredients
Frequently asked questions
- bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification listed in ECHA Annex VI and no SCCS or CIR safety assessment identifying reproductive hazard for this polymer. Peer‑reviewed or regulatory literature does not report teratogenicity or reproductive toxicity for the polymer itself; concerns would be about residual monomers such as HEMA or isocyanates, but no data show reproductive effects from the finished polymer as used in cosmetics (sources consulted: ECHA Annex VI, SCCS/CIR absence, PubMed absence).
- bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer est-il sûr pendant l'allaitement ?
- As for pregnancy: the polymer has high molecular weight and is expected to have negligible systemic absorption when applied topically; no evidence of transfer via breastmilk for the polymer itself reported in regulatory or peer‑reviewed sources. Potential issue would be unreacted monomers, but no regulatory assessments identify breastfeeding risk for the finished polymer (sources: CIR/SCCS absence, PubMed absence, CosIng/ECHA listings if present without classification).
- bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer est-il sûr pour la peau de bébé ?
- High molecular weight polymeric material is expected to have negligible dermal absorption in adults and in infants; no data indicate infant‑specific reproductive mechanism or developmental toxicity from the polymer. Because the polymer is large and crosslinked, dermal penetration is unlikely; therefore exposure for 0–3 y is considered negligible. Note: if residual low‑MW monomers/oligomers (HEMA, IPDI fragments) are present at meaningful levels, infant exposure could be higher—no data on residual monomer content were found (sources: ECHA, CosIng, PubMed).
- Comment VeriMom évalue-t-il bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer ?
- VeriMom évalue bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à bis-hema poly(1,4-butanediol)-22/dmpa/neopentyl glycol/ipdi copolymer basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.